---
figid: PMC9042933__41416_2021_1642_Fig3_HTML
pmcid: PMC9042933
image_filename: 41416_2021_1642_Fig3_HTML.jpg
figure_link: /pmc/articles/PMC9042933/figure/Fig3/
number: Fig. 3
figure_title: Percentage of KEAP1, NFE2L2 and CUL3 somatic mutations across the different
  lung cancer subtypes
caption: 'KEAP1: lung adenosquamous carcinoma (38.1%), lung adenocarcinoma (14.72%),
  non-small cell lung cancer (14.7%), lung squamous cell carcinoma (9.74%), and small
  cell lung cancer (1.57%) (top panel); NFE2L2: lung squamous cell carcinoma (15.87%),
  non-small cell lung cancer (5.73%), lung adenocarcinoma (2.67%), and small cell
  lung cancer (1.18%) (middle panel); CUL3: lung squamous cell carcinoma (5.86%),
  lung adenocarcinoma (2.1%), small cell lung cancer (0.79%) and non-small cell lung
  cancer (0.72%) (bottom panel) [, ].'
article_title: Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human
  lung cancer.
citation: Nuria Cami√±a, et al. Br J Cancer. 2022 May 18;126(9):1244-1252.
year: '2022'

doi: 10.1038/s41416-021-01642-0
journal_title: British Journal of Cancer
journal_nlm_ta: Br J Cancer
publisher_name: Nature Publishing Group UK

keywords:
- Cancer
- Lung cancer

---
